Risultati per: Guida pratica all’uso farmaci ipoglicemizzanti inclusi nella Nota 100 AIFA

Secondo il Regolamento, interim al membro Cda di nomina del ministro

Curata da Arrigoni, Malafarina e Sani e promossa dalla Cpo

Le dimissioni arrivano alla fine del completamento della riforma dell’Agenzia e a due settimane dalla sua riconferma alla presidenza

Totale assenza di ascolto da parte di Schillaci

Ridurranno del 70% gli esami inutili

Operazione contro il crimine farmaceutico, 5 arresti

Esperti, ‘fa guadagnare ai pazienti ulteriori mesi e anni di vita’

Circulation, Ahead of Print. In 1924, the founders of the American Heart Association (AHA) envisioned an international society focused on the heart and aimed at facilitating research, disseminating information, increasing public awareness, and developing public health policy related to heart disease. This presidential advisory provides a comprehensive review of the past century of cardiovascular and stroke science, with a focus on the AHA’s contributions, as well as informed speculation about the future of cardiovascular science into the next century of the organization’s history. The AHA is a leader in fundamental, translational, clinical, and population science, and it promotes the concept of the “learning health system,” in which a continuous cycle of evidence-based practice leads to practice-based evidence, permitting an iterative refinement in clinical evidence and care. This advisory presents the AHA’s journey over the past century from instituting professional membership to establishing extraordinary research funding programs; translating evidence to practice through clinical practice guidelines; affecting systems of care through quality programs, certification, and implementation; leading important advocacy efforts at the federal, state and local levels; and building global coalitions around cardiovascular and stroke science and public health. Recognizing an exciting potential future for science and medicine, the advisory offers a vision for even greater impact for the AHA’s second century in its continued mission to be a relentless force for longer, healthier lives.

Nominato per la prima volta nel dicembre 2020, in piena era Covid

‘Lavoro frutto di anni di dialogo con il Garante’